Orphan line

“Orphan drugs” are medicinal products intended for diagnosis, prevention or treatment of life-threatening or very serious diseases or disorders that are rare.

A disease or disorder is defined as rare in Europe when it affects less than 1 in 2,000 citizens.

These drugs are called “orphan” because under normal market conditions the pharmaceutical industry has little interest in developing and marketing products intended for only a small number of patients.

For drug companies, the extremely high cost of bringing a medicinal product to market would not be recovered by the expected sales of the product.

We are able to provide medicines under this category. please contact us for further information.